DE602006011649D1 - Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten - Google Patents

Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten

Info

Publication number
DE602006011649D1
DE602006011649D1 DE602006011649T DE602006011649T DE602006011649D1 DE 602006011649 D1 DE602006011649 D1 DE 602006011649D1 DE 602006011649 T DE602006011649 T DE 602006011649T DE 602006011649 T DE602006011649 T DE 602006011649T DE 602006011649 D1 DE602006011649 D1 DE 602006011649D1
Authority
DE
Germany
Prior art keywords
derivatives
production
compositions containing
therapeutic compositions
indicative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006011649T
Other languages
English (en)
Inventor
Patrick Gautier
David Marchionni
Alain Roccon
Bernard Tonnerre
Jean Wagnon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37027751&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602006011649(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602006011649D1 publication Critical patent/DE602006011649D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DE602006011649T 2005-11-23 2006-11-21 Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten Active DE602006011649D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0511849A FR2893616B1 (fr) 2005-11-23 2005-11-23 Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
PCT/FR2006/002551 WO2007060318A1 (fr) 2005-11-23 2006-11-21 Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant.

Publications (1)

Publication Number Publication Date
DE602006011649D1 true DE602006011649D1 (de) 2010-02-25

Family

ID=37027751

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006011649T Active DE602006011649D1 (de) 2005-11-23 2006-11-21 Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten

Country Status (34)

Country Link
US (1) US7799799B2 (de)
EP (1) EP1957490B1 (de)
JP (1) JP5372514B2 (de)
KR (1) KR101419066B1 (de)
CN (1) CN101312973B (de)
AR (1) AR058208A1 (de)
AT (1) ATE454386T1 (de)
AU (1) AU2006316381B2 (de)
BR (1) BRPI0618975A2 (de)
CA (1) CA2629738C (de)
CR (1) CR9927A (de)
CY (1) CY1110623T1 (de)
DE (1) DE602006011649D1 (de)
DK (1) DK1957490T3 (de)
DO (1) DOP2006000254A (de)
EA (1) EA014158B1 (de)
EC (1) ECSP088455A (de)
ES (1) ES2338922T3 (de)
FR (1) FR2893616B1 (de)
GT (1) GT200600489A (de)
HK (1) HK1126198A1 (de)
HR (1) HRP20100158T1 (de)
IL (1) IL190861A (de)
MA (1) MA30055B1 (de)
NO (1) NO20082589L (de)
PE (1) PE20071083A1 (de)
PL (1) PL1957490T3 (de)
PT (1) PT1957490E (de)
SI (1) SI1957490T1 (de)
TN (1) TNSN08162A1 (de)
TW (1) TW200738705A (de)
UY (1) UY29965A1 (de)
WO (1) WO2007060318A1 (de)
ZA (1) ZA200803565B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant
FR2962438B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'indolizines, procedes de preparation et application en therapeutique
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
CN103360390B (zh) * 2013-07-23 2015-06-17 东南大学 中氮茚甲酰甲基对甲磺酰胺苯乙胺衍生物及其医药用途
CN110156776A (zh) * 2019-04-30 2019-08-23 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 一种c-3芳甲酰基吲嗪类化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI61030C (fi) * 1976-02-19 1982-05-10 Sanofi Sa Foerfarande foer framstaellning av terapeutiskt verkande 2-substituerade-1- eller 3-benzoyl-indolizinderivat
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
US5334716A (en) * 1991-06-17 1994-08-02 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic derivatives
US6593322B1 (en) * 1999-03-17 2003-07-15 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
FR2813306B1 (fr) * 2000-08-23 2005-10-21 Sanofi Synthelabo Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant
FR2893616B1 (fr) 2005-11-23 2008-01-04 Sanofi Aventis Sa Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant

Also Published As

Publication number Publication date
US20080287485A1 (en) 2008-11-20
JP2009516725A (ja) 2009-04-23
IL190861A0 (en) 2008-11-03
CA2629738C (fr) 2014-09-23
ES2338922T3 (es) 2010-05-13
CR9927A (es) 2008-10-06
DK1957490T3 (da) 2010-05-10
KR101419066B1 (ko) 2014-07-11
BRPI0618975A2 (pt) 2011-09-20
CN101312973A (zh) 2008-11-26
NO20082589L (no) 2008-06-10
UY29965A1 (es) 2007-06-29
HK1126198A1 (en) 2009-08-28
JP5372514B2 (ja) 2013-12-18
EA014158B1 (ru) 2010-10-29
MA30055B1 (fr) 2008-12-01
ZA200803565B (en) 2009-12-30
AR058208A1 (es) 2008-01-23
HRP20100158T1 (hr) 2010-05-31
SI1957490T1 (sl) 2010-04-30
DOP2006000254A (es) 2007-06-15
IL190861A (en) 2013-02-28
CA2629738A1 (fr) 2007-05-31
CY1110623T1 (el) 2015-04-29
ECSP088455A (es) 2008-06-30
FR2893616A1 (fr) 2007-05-25
AU2006316381B2 (en) 2012-05-31
WO2007060318A1 (fr) 2007-05-31
PE20071083A1 (es) 2007-12-03
KR20080072000A (ko) 2008-08-05
TW200738705A (en) 2007-10-16
EA200801400A1 (ru) 2008-10-30
EP1957490A1 (de) 2008-08-20
FR2893616B1 (fr) 2008-01-04
PL1957490T3 (pl) 2010-07-30
EP1957490B1 (de) 2010-01-06
TNSN08162A1 (en) 2009-10-30
CN101312973B (zh) 2011-12-28
US7799799B2 (en) 2010-09-21
PT1957490E (pt) 2010-03-29
ATE454386T1 (de) 2010-01-15
GT200600489A (es) 2007-09-19
AU2006316381A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
ATE471930T1 (de) 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
ATE459623T1 (de) Pyridoä2,3-düpyrimidine, die sich als hcv- inhibitoren eignen und verfahren zu deren herstellung
DE602005007419D1 (de) Rohmix-pulverzusammensetzungen und verfahren zu deren herstellung
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE556077T1 (de) Tetrahydrochinolinderivate und verfahren zu deren herstellung
DE502007006055D1 (de) Neue mit benzylresten substituierte 1,4-benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
ATE496919T1 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
ATE490256T1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE374172T1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE441638T1 (de) 4,5-diphenyl-pyrimidinyl substituierte carbonsäuren, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE602005018911D1 (de) 1,4-Dihydropyridine-kondensierte Heterocyclen Verfahren zu deren Herstellung sowie Verwendung und Zusammensetzungen dergleichen
ATE482193T1 (de) Indolonacetamidderivate, verfahren zu deren herstellung und deren verwendungen
ATE502024T1 (de) Diosmetin-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE502006009351D1 (de) Feinteiliges azopigment und verfahren zu seiner herstellung
ATE535510T1 (de) Benzylamine, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmende mittel
ATE372992T1 (de) Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE503749T1 (de) Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon
ATE381338T1 (de) Benzothiadiazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen,die diese enthalten
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE462408T1 (de) Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung
DE602006011649D1 (de) Neue indolizinderivate, verfahren zu deren herstellung und therapeutische zusammensetzungen, die diese enthalten
DE602005002138D1 (de) Pentensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und deren therapeutische anwendung
ATE388936T1 (de) 9-chloro-15-deoxyprostaglandinderivate, verfahren zu ihrer herstellung und deren verwendung als medikamente
ATE487706T1 (de) Cyclische n-ä1,3,4ü-thiadiazol-2-yl- benzsulfonamide, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE112007001661A5 (de) Neue wasserstoffreiche 1,3-Dialkoxy-disiloxane sowie Verfahren zu deren Herstellung und deren Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition